Shaily Engineering Plastics Limited (SEPL) has reported strong financial results for the first quarter of fiscal year 2026, with significant growth across key metrics. The company's focus on the healthcare segment, particularly in GLP-1 pen devices, has been a major driver of its performance.

Financial Highlights

• Revenue surged by 38% year-on-year to ₹246.70 crores
• EBITDA jumped 95% to ₹70.40 crores, with margins expanding to 28.5%
• Profit After Tax (PAT) increased by 136% to ₹41.10 crores
• Cash PAT stood at ₹52.60 crores, up 91% year-on-year

Segment Performance

• Healthcare segment revenue soared 181% to ₹77.20 crores, now contributing 31% of total revenue
• Consumer segment revenue grew 14% to ₹151.40 crores
• Industrial segment revenue slightly declined to ₹18.10 crores

Operational Highlights

• Processed 7,016 tonnes of polymers, up from 5,902 tonnes in Q1 FY25
• Machine utilization rate improved to 49%, compared to 39% in the same quarter last year
• Exports accounted for 76% of total revenue

Healthcare Segment Expansion

SEPL has made significant strides in its healthcare business, particularly in GLP-1 pen devices:

• Commenced commercial manufacturing of GLP-1 pens for semaglutide
• Installed capacity for an additional 25 million pens per annum, expected to be operational by the end of Q2 FY26
• Planning another expansion of 25 million pens for a variant of semaglutide pen
• Total planned capex of ₹125.00 crores for capacity expansion in FY26

Future Outlook

• The company expects the healthcare segment to drive significant revenue and profitability growth
• Management is in discussions with multiple customers regarding volume commitments and capacity requirements for the next 3 to 5 years
• SEPL is aligning its manufacturing capacity and global footprint accordingly

Management Commentary

Amit Sanghvi, Managing Director of Shaily Engineering Plastics Limited, commented on the results: "We have delivered strong revenue growth of 38% year-on-year to ₹247 crores with an EBITDA margin expanding by 840 basis points to 28.5%. The growth is attributable to improved traction in our Healthcare segment, which shows a growth of 181% year-on-year to ₹77 crores."

He further added, "We're on track with our guidance expecting health care business to contribute significantly to our revenue and profitability over the next couple of years, thereby enhancing the organizational value."

Conclusion

Shaily Engineering Plastics Limited's Q1 FY26 results demonstrate the company's strong growth trajectory, particularly in the healthcare segment. With ongoing expansions and a focus on GLP-1 pen devices, SEPL is well-positioned to capitalize on the growing demand in the pharmaceutical industry. Investors will be watching closely to see if the company can maintain this momentum in the coming quarters.

Shaily Engineering Plastics Limited (SEPL) has reported its financial results for the first quarter, demonstrating solid performance across various financial metrics.

Financial Highlights

For the quarter ended June 30, SEPL reported the following standalone results:

On a consolidated basis, the company achieved:

Corporate Developments

Re-appointment of Whole-time Director

The Board of Directors has approved the re-appointment of Mrs. Tilottama Sanghvi as Whole-time Director for a three-year term from February 1, 2026, to January 31, 2029. This appointment is subject to shareholder approval at the upcoming 45th Annual General Meeting.

Dividend Record Date

SEPL has set September 19, 2025, as the record date for determining shareholders eligible for the final dividend distribution for the financial year 2024-25.

Corporate Governance

The Board has approved a revised Code of Conduct for Prevention of Insider Trading, reinforcing the company's commitment to ethical business practices.

International Expansion

SEPL made a strategic investment of AED 100,000 in its wholly-owned subsidiary, Shaily Innovations FZCO, located in Dubai. This move signals the company's efforts to strengthen its international presence and explore new market opportunities.

The robust financial performance and strategic initiatives undertaken by Shaily Engineering Plastics Limited indicate a positive outlook for the company.